Intervention effect and mechanism of Dracocephalum moldavica L. extract on bleomycin-induced pulmonary fibrosis in rats

Intervention effect and mechanism of Dracocephalum moldavica L. extract on bleomycin-induced pulmonary fibrosis in rats

BackgroundExposures to environmental pollution and specific occupational hazards exacerbate pulmonary fibrosis which has a complex pathogenesis and lacks effective therapeutic drugs. The extract from Dracocephalum moldavica L. can alleviate pulmonary fibrosis through anti-inflammatory and anti-pyrop...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoyu SUN, Li CHEN, Ruifang GAO, Hui YU, Min JIN
Format:	Article
Language:	English
Published:	Editorial Committee of Journal of Environmental and Occupational Medicine 2024-12-01
Series:	环境与职业医学
Subjects:	pulmonary fibrosis dracocephalum moldavica l. extract phosphoinositide 3-kinase/protein kinase b inflammatory network pharmacology animal experiment validation
Online Access:	http://www.jeom.org/article/cn/10.11836/JEOM24121
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease
by: Marjan Talebi, et al.
Published: (2025-02-01)

Promising Neuroprotective Effects of Dracocephalum Species: Mechanistic Perspectives
by: Marjan Talebi, et al.
Published: (2024-12-01)

Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
by: Kangchen Li, et al.
Published: (2025-01-01)

HMGB1 Box A gene therapy to alleviate bleomycin-induced pulmonary fibrosis in rats
by: Rathasapa Patarat, et al.
Published: (2025-01-01)

Expanding the therapeutic horizon in acute myeloid leukemia: The role of phosphoinositide-3-kinase-γ inhibition
by: Soumyajit Das, et al.
Published: (2024-12-01)

Paradoxical dominant negative activity of an immunodeficiency-associated activating PIK3R1 variant
by: Patsy R Tomlinson, et al.
Published: (2025-01-01)

Screening and identification of host signaling pathways for alleviating influenza-induced production of pro-inflammatory cytokines, IP-10, IL-8, and MCP-1, using a U937 cell-based influenza model
by: Si Chen, et al.
Published: (2025-01-01)

Network pharmacology and experimental verification reveal the mechanism of Qingfei Tongluo mixture in treating pulmonary fibrosis
by: Ying Zhou, et al.
Published: (2025-01-01)

Effects of Sildenafil and Vitamin E on Paraquat-Induced Pulmonary Fibrosis in Rats
by: Fouziyeh Siahpour, et al.
Published: (2024-12-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01)

Serum Pharmacochemistry and Network Pharmacology Reveal Active Compounds and Mechanisms of the Huaxian Formula in Alleviating Radiation-Induced Pulmonary Fibrosis
by: Gong C, et al.
Published: (2025-01-01)

Focal adhesion kinase promotes aerobic glycolysis in hepatic stellate cells via the cyclin D1/c-Myc/MCT-1 pathway to induce liver fibrosis
by: Tao Huang, et al.
Published: (2025-02-01)

Prevalence of pulmonary arterial hypertension in post-tuberculosis lung fibrosis patients: A cross-sectional observational study
by: Rupak Chatterjee, et al.
Published: (2023-12-01)

Human neural stem cell–derived extracellular vesicles protect against ischemic stroke by activating the PI3K/AKT/mTOR pathway
by: Jiayi Wang, et al.
Published: (2025-11-01)

An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review
by: Shu-Cheng Wu, et al.
Published: (2024-01-01)

Orientin and vitexin attenuate lipopolysaccharide-induced inflammatory responses in RAW264.7 cells: a molecular docking study, biochemical characterization, and mechanism analysis
by: Yue Yu, et al.
Published: (2022-09-01)

Treatment patterns and clinical profile in progressive pulmonary fibrosis: a Japanese cross-sectional survey
by: Hidekata Yasuoka, et al.
Published: (2025-01-01)

Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
by: Guanqi Dai, et al.
Published: (2025-01-01)

Editorial: Exploring novel approaches to small molecule kinase inhibitors in cancer treatment
by: Anna Carbone, et al.
Published: (2025-02-01)

The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury
by: Xiaoling Zhong, et al.
Published: (2025-11-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)
by: María Reyes Abad, et al.
Published: (2025-01-01)

A Multi-ingredient Supplement Reduced Markers of Muscle Damage after a Rugby Match in Collegiate Male Players
by: Chang-Li Hsueh, et al.
Published: (2024-12-01)

Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)

Quality of life in idiopathic pulmonary fibrosis in Latin American countries
by: H. Aguilar-Duran, et al.
Published: (2025-01-01)

Association between fluoride exposure and the risk of serum CK and CK-MB elevation in adults: a cross-sectional study in China
by: Junhua Wu, et al.
Published: (2025-01-01)

CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
by: Jiwei Hou, et al.
Published: (2025-01-01)

Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension
by: Shameek Gayen, et al.
Published: (2025-02-01)

An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
by: Russell J. Schilder, et al.
Published: (2025-03-01)

Identification and Analysis of Key Immune- and Inflammation-Related Genes in Idiopathic Pulmonary Fibrosis
by: Tan Y, et al.
Published: (2025-02-01)

Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials
by: José Pinto-Fraga, et al.
Published: (2025-02-01)

Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study
by: Athol U. Wells, et al.
Published: (2024-12-01)

Machine learning potential predictor of idiopathic pulmonary fibrosis
by: Chenchun Ding, et al.
Published: (2025-01-01)

Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis
by: Wonseok Whi, et al.
Published: (2025-01-01)

Integrating machine learning and structure-based approaches for repurposing potent tyrosine protein kinase Src inhibitors to treat inflammatory disorders
by: Muhammad Waleed Iqbal, et al.
Published: (2025-01-01)

Ultrasound‐Activated Precise Sono‐Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis
by: Xiang Li, et al.
Published: (2025-02-01)

Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
by: Zhe Chen, et al.
Published: (2025-01-01)

Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients
by: Agata Maciejewska, et al.
Published: (2025-01-01)

HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders
by: Qin Wang, et al.
Published: (2025-02-01)

A study examining the effects of changed rules of wrestling competitions on the muscular damage levels of the elite wrestlers
by: C. Berkan Alpay, et al.
Published: (2014-06-01)